Salmon calcitonin

DRUG4 trials

Sponsors

Novartis, Rene Rizzoli, Eli Lilly and Company, Unidad de Investigacion en Enfermedades Cronico-Degenerativas

Conditions

FibromyalgiaForearm FractureOsteoporosisPostmenopause

Phase 3

Bone Microstructure in Nasal Salmon Calcitonin Treated Postmenopausal Women

CompletedNCT00372099

Rene RizzoliPostmenopause

Start: 2007-01-31End: 2011-11-30Updated: 2011-12-23

A Study for Patients With Osteoporosis

CompletedNCT00414973

Eli Lilly and CompanyOsteoporosis

Start: 2006-12-31End: 2008-07-31Updated: 2009-10-28

Phase 4

Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women

CompletedNCT00239889

NovartisForearm Fracture

Start: 2002-03-31Target: 300Updated: 2006-11-30

Calcitonin in the Treatment of Fibromyalgia

WithdrawnNCT00754884

Unidad de Investigacion en Enfermedades Cronico-DegenerativasFibromyalgia

Start: 2008-10-31End: 2009-02-28Updated: 2015-12-04

Related Papers

Effects of teriparatide in Chinese and Caucasian women with osteoporosis: bridging study on efficacy.

2019-05-272 citations

A randomized double-blind placebo-controlled trial to investigate the effects of nasal calcitonin on bone microarchitecture measured by high-resolution peripheral quantitative computerized tomography in postmenopausal women - study protocol.

2008-04-132 citations